TNFRSF9 and neoplasm: (43) found that cell lines from hepatocellular tumors, lung, renal, and melanoma selectively expressed sCD137 but not membrane-bound CD137 (mCD137) under hypoxia condition, suggesting sCD137 was beneficial for tumor survival.